Aggregate formation and the impairment of long-term synaptic facilitation by ectopic expression of mutant huntingtin in Aplysia neurons

J Neurochem. 2003 Apr;85(1):160-9. doi: 10.1046/j.1471-4159.2003.01650.x.

Abstract

Huntington's disease (HD) is caused by an expansion of a polyglutamine (polyQ) tract within huntingtin (htt) protein. To examine the cytotoxic effects of polyQ-expanded htt, we overexpressed an enhanced green fluorescent protein (EGFP)-tagged N-terminal fragment of htt with 150 glutamine residues (Nhtt150Q-EGFP) in Aplysia neurons. A combined confocal and electron microscopic study showed that Aplysia neurons expressing Nhtt150Q-EGFP displayed numerous abnormal aggregates (diameter 0.5-5 microm) of filamentous structures, which were formed rapidly (approximately 2 h) but which were sustained for at least 18 days in the cytoplasm. Furthermore, the overexpression of Nhtt150Q-EGFP in sensory cells impaired 5-hydroxytryptamine (5-HT)-induced long-term synaptic facilitation in sensori-motor synapses without affecting basal synaptic strength or short-term facilitation. This study demonstrates the stability of polyQ-based aggregates and their specific effects on long-term synaptic plasticity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aplysia
  • Cells, Cultured
  • Cytoplasm / metabolism
  • Cytoplasm / ultrastructure
  • Huntington Disease* / genetics
  • Long-Term Potentiation / drug effects
  • Long-Term Potentiation / physiology*
  • Luminescent Proteins / genetics
  • Macromolecular Substances
  • Microinjections
  • Motor Neurons / drug effects
  • Motor Neurons / metabolism
  • Motor Neurons / ultrastructure
  • Mutation
  • Nerve Tissue Proteins / biosynthesis*
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / pharmacology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Neurons / ultrastructure
  • Neurons, Afferent / drug effects
  • Neurons, Afferent / metabolism
  • Neurons, Afferent / ultrastructure
  • Nuclear Proteins / biosynthesis*
  • Nuclear Proteins / genetics
  • Nuclear Proteins / pharmacology
  • Peptide Fragments / genetics
  • Recombinant Fusion Proteins / biosynthesis
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / pharmacology
  • Serotonin / pharmacology
  • Synapses / metabolism*
  • Trinucleotide Repeat Expansion

Substances

  • Luminescent Proteins
  • Macromolecular Substances
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • Peptide Fragments
  • Recombinant Fusion Proteins
  • Serotonin